Submitted by Anonymous (not verified) on 17 December 2025 - 15:40
Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 47, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 47, Status: Authorised